Literature DB >> 3365029

Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.

P W Thompson1, J R Kirwan, D D Jones, H L Currey.   

Abstract

Increases in joint inflammation in nine patients with rheumatoid arthritis were provoked by withdrawal of their non-steroidal anti-inflammatory drugs. Pain score, duration of morning stiffness, Ritchie articular index score, and the number of analgesic tablets consumed reached peaks after five, three, five, and five days respectively compared with values during six days of normal treatment. Changes in serum cytidine deaminase (believed to reflect polymorph turnover in inflamed joints) showed a different pattern, with a sharp peak after two days and a subsequent trough. Possible mechanisms for these differences are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365029      PMCID: PMC1003512          DOI: 10.1136/ard.47.4.308

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  11 in total

1.  Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteers.

Authors:  A Scheja; A Forsgren; K Ohlsson; F A Wollheim
Journal:  Clin Exp Rheumatol       Date:  1986 Jan-Mar       Impact factor: 4.473

2.  A simple, direct, and sensitive technique for measurement of specific protein in dilute solution.

Authors:  R F Ritchie
Journal:  J Lab Clin Med       Date:  1967-09

3.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

4.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

5.  Laboratory markers of joint inflammation and damage.

Authors:  P W Thompson
Journal:  Br J Rheumatol       Date:  1987-04

6.  Rheumatoid arthritis--anti-inflammatory drugs.

Authors:  H E Paulus
Journal:  Clin Rheum Dis       Date:  1983-12

7.  Inhibition of in vivo leucocyte migration by NSAIDs.

Authors:  A Scheja; A Forsgren; L Marsal; F Wollheim
Journal:  Clin Exp Rheumatol       Date:  1985 Jan-Mar       Impact factor: 4.473

8.  Activity of serum cytidine deaminase during pregnancy.

Authors:  D D Jones; S Bahijri; E L Roberts; G F Williams
Journal:  Br J Obstet Gynaecol       Date:  1982-04

9.  Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.

Authors:  P W Thompson; D D Jones; H L Currey
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

10.  Granulocyte survival in synovial exudate of patients with rheumatoid arthritis and other inflammatory joint diseases.

Authors:  J W Hollingsworth; E R Siegel; W A Creasey
Journal:  Yale J Biol Med       Date:  1967-04
View more
  4 in total

1.  Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis.

Authors:  Sergio Paira; Susana Roverano; Oscar Rillo; Alejandra Barrionuevo; Stella Mahieu; Néstor Millen
Journal:  Clin Rheumatol       Date:  2005-01-22       Impact factor: 2.980

2.  Activities of adenosine deaminase, 5'-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues.

Authors:  O Canbolat; I Durak; R Cetin; M Kavutcu; S Demirci; S Oztürk
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.

Authors:  R Cohen; L H Preta; V Joste; E Curis; O Huillard; A Jouinot; C Narjoz; A Thomas-Schoemann; A Bellesoeur; M Tiako Meyo; J Quilichini; D Desaulle; I Nicolis; A Cessot; M Vidal; F Goldwasser; J Alexandre; B Blanchet
Journal:  Br J Clin Pharmacol       Date:  2019-01-30       Impact factor: 4.335

4.  Circadian rhythm of serum cytidine deaminase in patients with rheumatoid arthritis during rest and exercise.

Authors:  P W Thompson; I T James; S Wheatcroft; R Pownall; C G Barnes
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.